ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 503,27
-2,66%
Dow Jones
38 589,16
-0,15%
DAX
18 002,02
-1,43%
Brent Oil
82,275
0,00%
Bitcoin
66 219,57
0,32%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Pandion Therapeutics Inc (PAND)

  7. Pandion Therapeutics Inc (PAND) Actualités

PAND

Pandion Therapeutics (PAND)

Pandion Therapeutics Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PAND
DateHeureSourceTitreSymboleSociété
17/05/202122h40Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PANDPandion Therapeutics Inc
12/04/202112h55Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(b) (15-12b)NASDAQ:PANDPandion Therapeutics Inc
08/04/202123h25Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:PANDPandion Therapeutics Inc
06/04/202112h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PANDPandion Therapeutics Inc
02/04/202101h56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114h50Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114h47Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114h44Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114h38Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:PANDPandion Therapeutics Inc
01/04/202114h26Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or ...NASDAQ:PANDPandion Therapeutics Inc
31/03/202122h03Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:PANDPandion Therapeutics Inc
12/03/202123h05Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PANDPandion Therapeutics Inc
04/03/202123h16Edgar (US Regulatory)Statement of Ownership: Solicitation (sc 14d9)NASDAQ:PANDPandion Therapeutics Inc
04/03/202122h49Edgar (US Regulatory)Statement of Beneficial Ownership (sc 13d)NASDAQ:PANDPandion Therapeutics Inc
04/03/202122h35Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:PANDPandion Therapeutics Inc
26/02/202122h59Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:PANDPandion Therapeutics Inc
26/02/202107h26TipRanksMerck Inks Deal To Buy Pandion Therapeutics For $1.85B; Shares SkyrocketNASDAQ:PANDPandion Therapeutics Inc
25/02/202122h02Edgar (US Regulatory)Written Communication Relating to an Issuer or Third Party (sc To-c)NASDAQ:PANDPandion Therapeutics Inc
25/02/202115h28Dow Jones NewsPandion Shares More Than Double Premarket on Takeover by MerckNASDAQ:PANDPandion Therapeutics Inc
25/02/202114h20Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PANDPandion Therapeutics Inc
25/02/202113h28Dow Jones NewsMerck to Buy Pandion Therapeutics for $1.85 BillionNASDAQ:PANDPandion Therapeutics Inc
25/02/202112h45Business WireMerck to Acquire Pandion TherapeuticsNASDAQ:PANDPandion Therapeutics Inc
22/02/202114h30GlobeNewswire Inc.Pandion Therapeutics Presents Preclinical Data Highlighting Potential of Tissue-Tethered PD-1 Agonist to Locally Target Autoi...NASDAQ:PANDPandion Therapeutics Inc
18/02/202114h30GlobeNewswire Inc.Pandion Therapeutics to Present at the 10th Annual SVB Leerink Global Healthcare ConferenceNASDAQ:PANDPandion Therapeutics Inc
16/02/202122h52Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:PANDPandion Therapeutics Inc
04/01/202114h00GlobeNewswire Inc.Pandion Therapeutics Announces Positive Top-Line Phase 1a Clinical Data Showing PT101 was Well-Tolerated and Selectively Expa...NASDAQ:PANDPandion Therapeutics Inc
03/12/202014h00GlobeNewswire Inc.Pandion Therapeutics Appoints Katina Dorton to its Board of DirectorsNASDAQ:PANDPandion Therapeutics Inc
16/11/202022h18Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PANDPandion Therapeutics Inc
16/11/202022h01GlobeNewswire Inc.Pandion Therapeutics Reports Third Quarter 2020 Financial Results and Provides Business UpdateNASDAQ:PANDPandion Therapeutics Inc
10/11/202014h00GlobeNewswire Inc.Pandion Therapeutics to Present at the Stifel 2020 Virtual Healthcare ConferenceNASDAQ:PANDPandion Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:PAND

Dernières Valeurs Consultées

BIT
P1ZKN0
NLBNPIT1ZKN0 20351221 12...
BIT
P1ZQO5
NLBNPIT1ZQO5 20240920 700
BIT
S24977
SG ISSUER
HUOB
GNTUSDT
LSE
WRES
W Resources
USOTC
CNMXF
Canamex Gold (CE)
NASDAQ
DCPH
Deciphera Pharmaceuticals
NASDAQ
VNLS
Vernalis
COIN
BLURUSD
Blur
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés